CN109844126A - 基于多孔膜的大分子递送系统 - Google Patents

基于多孔膜的大分子递送系统 Download PDF

Info

Publication number
CN109844126A
CN109844126A CN201780060638.6A CN201780060638A CN109844126A CN 109844126 A CN109844126 A CN 109844126A CN 201780060638 A CN201780060638 A CN 201780060638A CN 109844126 A CN109844126 A CN 109844126A
Authority
CN
China
Prior art keywords
cell
microns
hole
reagent
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201780060638.6A
Other languages
English (en)
Chinese (zh)
Inventor
F·法金
M·菲奥里诺
C·李
Y·杨
J·延
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of CN109844126A publication Critical patent/CN109844126A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/80—Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
CN201780060638.6A 2016-09-28 2017-09-28 基于多孔膜的大分子递送系统 Pending CN109844126A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662401053P 2016-09-28 2016-09-28
US62/401,053 2016-09-28
PCT/US2017/054110 WO2018064387A1 (en) 2016-09-28 2017-09-28 Porous membrane-based macromolecule delivery system

Publications (1)

Publication Number Publication Date
CN109844126A true CN109844126A (zh) 2019-06-04

Family

ID=60183103

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201780060638.6A Pending CN109844126A (zh) 2016-09-28 2017-09-28 基于多孔膜的大分子递送系统

Country Status (5)

Country Link
US (1) US20190203230A1 (cg-RX-API-DMAC7.html)
EP (1) EP3519577A1 (cg-RX-API-DMAC7.html)
JP (1) JP2019532672A (cg-RX-API-DMAC7.html)
CN (1) CN109844126A (cg-RX-API-DMAC7.html)
WO (1) WO2018064387A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116297429A (zh) * 2023-03-14 2023-06-23 青岛农业大学 一种检测农药的比色传感器、其制备方法及应用

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9017991B2 (en) 2009-03-13 2015-04-28 Tufts University Methods tip assemblies and kits for introducing material into cells
CA2986310A1 (en) 2015-05-11 2016-11-17 Editas Medicine, Inc. Optimized crispr/cas9 systems and methods for gene editing in stem cells
US11911415B2 (en) 2015-06-09 2024-02-27 Editas Medicine, Inc. CRISPR/Cas-related methods and compositions for improving transplantation
TW201839136A (zh) 2017-02-06 2018-11-01 瑞士商諾華公司 治療血色素異常症之組合物及方法
EP3652312A1 (en) 2017-07-14 2020-05-20 Editas Medicine, Inc. Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites
CN110272810A (zh) * 2019-07-01 2019-09-24 广州世赛生物科技有限公司 外源物质递送至真核细胞内的装置和方法及其应用
EP4337769A1 (en) * 2021-05-10 2024-03-20 SQZ Biotechnologies Company Methods for delivering genome editing molecules to the nucleus or cytosol of a cell and uses thereof
WO2024072514A1 (en) * 2022-09-30 2024-04-04 Xellar, Inc. Edge effect systems and methods for functionalized microfluidic devices
CN121399269A (zh) * 2023-05-15 2026-01-23 波特尔生物技术有限公司 基因编辑复合物及其组合的细胞递送

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015148842A1 (en) * 2014-03-28 2015-10-01 The Regents Of The University Of California Efficient delivery of large cargos into cells on a porous substrate
WO2016070136A1 (en) * 2014-10-31 2016-05-06 Massachusetts Institute Of Technology Delivery of biomolecules to immune cells
WO2016115179A1 (en) * 2015-01-12 2016-07-21 Massachusetts Institute Of Technology Gene editing through microfluidic delivery
CN108138118A (zh) * 2015-09-04 2018-06-08 Sqz生物技术公司 由具孔表面介导的生物分子的细胞内递送

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7687267B2 (en) * 2006-09-30 2010-03-30 Rational Biotechnology Inc. High-throughput cell transfection device and methods of using thereof
US20110213288A1 (en) * 2007-04-23 2011-09-01 The Board Of Regents, The University Of Texas System Device And Method For Transfecting Cells For Therapeutic Uses
PE20100362A1 (es) 2008-10-30 2010-05-27 Irm Llc Derivados de purina que expanden las celulas madre hematopoyeticas
US20110239315A1 (en) 2009-01-12 2011-09-29 Ulla Bonas Modular dna-binding domains and methods of use
EP2206723A1 (en) 2009-01-12 2010-07-14 Bonas, Ulla Modular DNA-binding domains
US20120244593A1 (en) * 2009-10-19 2012-09-27 Yong Huang Method, device and apparatus for inducing self-adjusting cell electroporation
US8956828B2 (en) 2009-11-10 2015-02-17 Sangamo Biosciences, Inc. Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
GB2481983A (en) 2010-07-12 2012-01-18 Hart Fenton & Co Ltd A ship including a gas tank room
CA2805442C (en) 2010-07-21 2020-05-12 Sangamo Biosciences, Inc. Methods and compositions for modification of an hla locus
SI2807165T1 (sl) 2012-01-27 2019-08-30 Universite De Montreal Pirimido(4,5-B)indol derivati in njihova uporaba pri ekspanziji hematopoetskih matičnih celic
ES2728782T3 (es) 2012-05-25 2019-10-28 Univ California Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN
US8697359B1 (en) 2012-12-12 2014-04-15 The Broad Institute, Inc. CRISPR-Cas systems and methods for altering expression of gene products
KR102955556B1 (ko) 2012-12-12 2026-04-22 더 브로드 인스티튜트, 인코퍼레이티드 서열 조작을 위한 crispr-cas 성분 시스템, 방법 및 조성물
CN105209621B (zh) 2012-12-12 2021-05-25 布罗德研究所有限公司 对用于序列操纵的改进的系统、方法和酶组合物进行的工程化和优化
SG11201505896YA (en) 2013-02-20 2015-09-29 Novartis Ag Treatment of cancer using humanized anti-egfrviii chimeric antigen receptor
WO2014130635A1 (en) 2013-02-20 2014-08-28 Novartis Ag Effective targeting of primary human leukemia using anti-cd123 chimeric antigen receptor engineered t cells
UY35468A (es) 2013-03-16 2014-10-31 Novartis Ag Tratamiento de cáncer utilizando un receptor quimérico de antígeno anti-cd19
EP3004339B1 (en) 2013-05-29 2021-07-07 Cellectis New compact scaffold of cas9 in the type ii crispr system
WO2015048577A2 (en) 2013-09-27 2015-04-02 Editas Medicine, Inc. Crispr-related methods and compositions
ES2918501T3 (es) 2013-12-19 2022-07-18 Novartis Ag Receptores de antígenos quiméricos de mesotelina humana y usos de los mismos
US20170015994A1 (en) * 2014-02-24 2017-01-19 Massachusetts Institute Of Technology Methods for in vivo genome editing
CN122399016A (zh) 2014-03-15 2026-07-17 诺华股份有限公司 使用嵌合抗原受体治疗癌症
WO2015191693A2 (en) * 2014-06-10 2015-12-17 Massachusetts Institute Of Technology Method for gene editing
JP6831777B2 (ja) 2014-07-21 2021-02-17 ノバルティス アーゲー Cd33キメラ抗原受容体を使用する癌の処置
BR112017000939A2 (pt) 2014-07-21 2017-11-14 Novartis Ag tratamento de câncer usando um receptor antigênico quimérico de cll-1
AU2015292744C1 (en) 2014-07-21 2021-01-21 Novartis Ag Treatment of cancer using humanized anti-BCMA chimeric antigen receptor
FR3024778B1 (fr) * 2014-08-05 2021-01-22 Screencell Procede pour le depistage de la drepanocytose et kit pour sa mise en oeuvre
EP3712171A1 (en) 2014-08-19 2020-09-23 Novartis AG Treatment of cancer using a cd123 chimeric antigen receptor
WO2016094880A1 (en) * 2014-12-12 2016-06-16 The Broad Institute Inc. Delivery, use and therapeutic applications of crispr systems and compositions for genome editing as to hematopoietic stem cells (hscs)
US20190024065A1 (en) * 2015-02-06 2019-01-24 Cellectis Primary hematopoietic cells genetically engineered by slow release of nucleic acids using nanoparticles
PL3280729T3 (pl) 2015-04-08 2022-08-22 Novartis Ag Terapie cd20, terapie cd22 i terapie skojarzone komórką eksprymującą chimeryczny receptor antygenowy (car) cd19
WO2017093969A1 (en) 2015-12-04 2017-06-08 Novartis Ag Compositions and methods for immunooncology
MX2018007987A (es) 2015-12-28 2019-01-10 Novartis Ag Composiciones y metodos para el tratamiento de hemoglobinopatias.

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015148842A1 (en) * 2014-03-28 2015-10-01 The Regents Of The University Of California Efficient delivery of large cargos into cells on a porous substrate
WO2016070136A1 (en) * 2014-10-31 2016-05-06 Massachusetts Institute Of Technology Delivery of biomolecules to immune cells
WO2016115179A1 (en) * 2015-01-12 2016-07-21 Massachusetts Institute Of Technology Gene editing through microfluidic delivery
CN108138118A (zh) * 2015-09-04 2018-06-08 Sqz生物技术公司 由具孔表面介导的生物分子的细胞内递送

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
A R WILLIAMS等: "Filtroporation: A simple, reliable technique for transfection and macromolecular loading of cells in suspension", 《BIOTECHNOL BIOENG》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116297429A (zh) * 2023-03-14 2023-06-23 青岛农业大学 一种检测农药的比色传感器、其制备方法及应用

Also Published As

Publication number Publication date
EP3519577A1 (en) 2019-08-07
JP2019532672A (ja) 2019-11-14
WO2018064387A1 (en) 2018-04-05
US20190203230A1 (en) 2019-07-04

Similar Documents

Publication Publication Date Title
JP7844400B2 (ja) 異常ヘモグロビン症の治療用組成物および方法
US20190203230A1 (en) Porous membrane-based macromolecule delivery system
Lee et al. Synthetically modified guide RNA and donor DNA are a versatile platform for CRISPR-Cas9 engineering
KR102630217B1 (ko) 혈색소병증의 치료를 위한 조성물 및 방법
CN107980059B (zh) 用于修饰基因组dna的方法和组合物
CN113302292B (zh) 遗传修饰细胞的减少和最少的操作制造
JP2024001075A (ja) 操作されたcas9ヌクレアーゼ
JP2021010366A (ja) ゲノムdnaを改変するための方法および組成物
CN111712569A (zh) 用于基因编辑的Cpf1-相关方法和组合物
EP3245294A1 (en) Gene editing through microfluidic delivery
JP2019520844A (ja) ゲノムdnaを改変するための方法および組成物
TW202016297A (zh) 抗藥性免疫細胞及使用其之方法
CN111004781A (zh) 长期扩增粒细胞-巨噬细胞祖细胞的方法及其应用
AU2023343318A1 (en) Immune cells having co-expressed tgfbr shrnas
CN118813625B (zh) 高度靶向人类HLA-A基因的sgRNA及应用
CN114929873A (zh) 使用靶向核酸酶调节微生物群的组成
CN118056014A (zh) 单碱基编辑修复hba2基因突变的方法及其应用
CN117535354B (zh) 一种修复hba2基因突变的方法、组合物及其应用
EP4342983A1 (en) Method for modifying cell
JP2025529224A (ja) 低免疫原性の免疫シナプス調節のための生体材料及びプロセス
EP4504221A2 (en) Compositions and methods for generating cells with reduced immunogenicty
CN115820737A (zh) 一种提高基因敲入效率的电穿孔转染体系制备方法
EP4574979A1 (en) Engineered immune cell and preparation method therefor
JP2024532305A (ja) 細胞を修飾する方法
Worthington Cellular and Molecular Mechanisms of Hematopoietic Stem Cell Regenerative Capacity Throughout Life

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20190604

WD01 Invention patent application deemed withdrawn after publication